Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)
Medical devices
Advice to medical device manufacturers - 2025 Timetable
Request for advice on the clinical development strategy and / or clinical investigations according to Article 61(2) of Regulation (EU) 2017/745 on from the medical device expert panels
Guide to manufacturers on the procedure for requesting advice from expert panels on clinical investigations and / or clinical development strategies for high-risk medical devices
Human medicines European public assessment report (EPAR): Bridion, sugammadex, Date of authorisation: 25/07/2008, Revision: 24, Status: Authorised
Linguistic review - Human
PSUSA/00003148/202405
Human medicines European public assessment report (EPAR): Kesimpta, ofatumumab, Date of authorisation: 26/03/2021, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Datroway, datopotamab deruxtecan, Status: Opinion